Pricing

Xenikos

0 followers

‌

Xenikos is developing a combination of two toxin-loaded anti-T-cell antibodies.

Industries

Biotechnology, Life Sciences

Employees

11-50

Links

Org chart

André de Lege

Controller & Accountant

Maria Marza Perez

CMC Project Manager

Jürgen van de Lagemaat

Director, Process Development & Commercialization

Board & advisors

Douglas E. Williams

Chairman

Francesco De Rubertis

Non-Executive Director

Jake Simson

Non-Executive Director

Teams

Leadership Team

2 people · 0 jobs

Offices

This company has no offices yet

Similar companies

Tango Therapeutics

3 followers

Science

6 followers

Cellares

4 followers

Amgen

273 followers

Pierre Fabre

15 followers

Revvity

8 followers

Kedrion Biopharma

19 followers

Novonesis

43 followers

Sanofi

279 followers

Gilead Sciences

157 followers

Regeneron

124 followers

Explore companies